Cryptococcal Disease in Diverse Hosts

N Engl J Med. 2024 May 2;390(17):1597-1610. doi: 10.1056/NEJMra2311057.

Authors

David B Meya¹, Peter R Williamson¹

Affiliation

¹ From the Infectious Diseases Institute and the Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda (D.B.M.); the Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis (D.B.M.); and the Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (P.R.W.).

PMID: 38692293
DOI: 10.1056/NEJMra2311057

No abstract available

Publication types

Review

MeSH terms

Antifungal Agents / therapeutic use
Antigens, Fungal / blood
Antigens, Fungal / cerebrospinal fluid
Cryptococcosis / diagnosis
Cryptococcosis / epidemiology
Cryptococcosis / immunology
Cryptococcosis / therapy
Cryptococcus* / immunology
Cryptococcus* / pathogenicity
HIV Infections / drug therapy
HIV Infections / immunology
Host-Pathogen Interactions / immunology
Humans
Immune Reconstitution Inflammatory Syndrome / etiology
Immunocompromised Host
Immunosuppressive Agents / adverse effects
Intracranial Hypertension / etiology
Intracranial Hypertension / therapy
Meningitis, Cryptococcal* / diagnosis
Meningitis, Cryptococcal* / epidemiology
Meningitis, Cryptococcal* / immunology
Meningitis, Cryptococcal* / therapy
Risk Factors

Substances

Antifungal Agents
Immunosuppressive Agents
Antigens, Fungal